Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating activities:
Net (loss) income	$ (92,791)	$ 28,790
Net loss from discontinued operations	40,112	23,812
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Stock-based compensation	9,996	7,880
Bad debt expense	1,839	0
Depreciation and amortization expense	6,422	0
Loss on impairment	0	3,000
Contingent consideration	0	(61)
Change in fair value of warrant liability	(535)	(565)
Fair value change of derivative liabilities	(5,554)	0
Changes in fair value of warrant liabilities	(5,148)	(90,138)
Gain on extinguishment of debt	(4,527)	0
(Gain) loss on asset disposal	(580)	26
Change in operating right-of-use assets	134	0
Debt discount	1,482	72
Changes in operating assets and liabilities:
Accounts receivable, net	553	0
Prepaid expenses and other current assets	(1,571)	954
Deferred rent assets	(1,626)	0
Accounts payable	(1,696)	(577)
Accrued expenses and other current liabilities	5,278	(1,378)
Deferred revenue	495	0
Net cash used in continuing operating activities	(47,717)	(28,185)
Net cash used in discontinued operating activities	(15,772)	(20,309)
Investing activities:
Proceeds from sale of property and equipment	2,289	0
Investment and acquisitions, net of cash acquired	(32,585)	0
Purchase of convertible note	0	(3,000)
Net Cash Provided by (Used in) Investing Activities, Continuing Operations	(30,296)	(3,000)
Net cash provided by (used in) discontinued investing activities	1,290	(11,829)
Financing activities:
Repayments of debt	(9,302)	0
Repayments under financing leases	(238)	0
Proceeds from recapitalization of PIC shares	0	75
Proceeds from exercise of stock options	630	230
Proceeds from exercise of Public Warrants	0	85,555
Buyout of redeemable noncontrolling interests and noncontrolling interests	(8,283)	0
Capital distributions to redeemable noncontrolling interests and noncontrolling interests	(1,895)	0
Net cash provided by (used in) continuing financing activities	(19,088)	85,860
Net cash used in discontinued financing activities	(99)	(502)
Net change in cash and cash equivalents and restricted cash	(111,682)	22,035
Cash, cash equivalents, and restricted cash at beginning of period	351,826	329,791
Cash, cash equivalents, and restricted cash at end of period	240,144	351,826
Supplemental disclosure of cash flow information:
Cash paid for interest	12,367	48
Supplemental disclosures of noncash investing and financing information:
Recording of operating lease asset and liability	1,827	0
Recording of finance lease asset and liability	23	0
Settlement of lease liability	685	0
Settlement of contingent liability through issuance of shares	186	0
Settlement of warrant liability upon exercise of Public Warrants	0	47,162
Settlement of warrant liability upon call of warrants	0	591
Issuance of shares to former owners of WEES	0	1,192
Equipment financing	$ 0	$ 271